Cargando…
Multimodality Treatment including Surgery Related to the Type of N2 Involvement in Locally Advanced Non-Small Cell Lung Cancer
SIMPLE SUMMARY: Multimodality therapy for locally advanced non-small cell lung cancer (NSCLC) is a complex and controversial issue, especially regarding optimal treatment regimens for patients with ipsilateral positive mediastinal nodes (N2 disease). Is the landscape in this hotly debated stage chan...
Autores principales: | Allaeys, Toon, Berzenji, Lawek, Lauwers, Patrick, Yogeswaran, Suresh Krishan, Hendriks, Jeroen M. H., Billiet, Charlotte, De Bondt, Charlotte, Van Schil, Paul E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997106/ https://www.ncbi.nlm.nih.gov/pubmed/35406428 http://dx.doi.org/10.3390/cancers14071656 |
Ejemplares similares
-
The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review
por: Berzenji, Lawek, et al.
Publicado: (2021) -
Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
por: Van Schil, Paul E., et al.
Publicado: (2017) -
Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
por: Berzenji, Lawek, et al.
Publicado: (2023) -
Surgery after Induction Targeted Therapy and Immunotherapy for Lung Cancer
por: Allaeys, Toon, et al.
Publicado: (2021) -
Good’s syndrome and COVID-19: case report and literature review
por: Berzenji, Lawek, et al.
Publicado: (2022)